Cargando…
Lung metastasectomy for colorectal cancer in the PulMiCC randomised controlled trial
Autores principales: | Treasure, Tom, Williams, Norman R |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8454816/ https://www.ncbi.nlm.nih.gov/pubmed/34557807 http://dx.doi.org/10.1016/j.lanepe.2021.100080 |
Ejemplares similares
-
Lung metastasectomy for colorectal cancer in the PulMiCC randomised controlled trial – Authors’ reply
por: Osterlund, Pia, et al.
Publicado: (2021) -
Pulmonary Metastasectomy versus Continued Active Monitoring in Colorectal Cancer (PulMiCC): a multicentre randomised clinical trial
por: Treasure, Tom, et al.
Publicado: (2019) -
The full cohort of 512 patients and the nested controlled trial in 93 patients in the Pulmonary Metastasectomy in Colorectal Cancer (PulMiCC) study raise doubts about the effective size at present claimed
por: Treasure, Tom, et al.
Publicado: (2022) -
Reply to: The PulMiCC Trial Provides Control Data for Colorectal Lung Metastases Amenable to Local Treatments
por: Bhartia, Bobby, et al.
Publicado: (2021) -
Comment on: ‘KRAS and BRAF mutations are prognostic biomarkers in patients undergoing lung metastasectomy of colorectal cancer.' Variation in survival associated with proto-oncongenes is not evidence for effectiveness of lung metastasectomy
por: Cardillo, Giuseppe, et al.
Publicado: (2015)